U-Best Innovative Technology Co., Ltd. (TPEX:4714)

Market Cap	3.54B
Revenue (ttm)	990.28M
Net Income (ttm)	98.70M
Shares Out	177.89M
EPS (ttm)	0.55
PE Ratio	36.06
Forward PE	n/a
Dividend	0.20 (1.01%)
Ex-Dividend Date	n/a

Volume	312,000
Average Volume	3,430,108
Open	20.60
Previous Close	19.90
Day's Range	20.50 - 21.55
52-Week Range	12.75 - 22.65
Beta	0.62
RSI	65.44
Earnings Date	Aug 8, 2025

About Lumos Pharma

U-Best Innovative Technology Co., Ltd., together with its subsidiaries, manufactures and trades in polymer chemical raw materials in Taiwan and internationally. It operates through U-BEST, Feei Cherng, Hsin-Li Chemical, and Sen Tai segments. The company offers polyurethane (PU) synthetic resins, PU adhesives, surface treatment agents, and solvents; nylon resins, polyester polyols, composite materials and raw materials, water-based resins, bridging agents, wet curing reactive hot melt adhesives, polyester polyols, plastic polyurethane elastomer ...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4714

Financial Performance

In 2024, TPEX:4714's revenue was 825.78 million, an increase of 59.88% compared to the previous year's 516.51 million. Earnings were 64.92 million, an increase of 226.48%.